

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | peptidyl-proline hydroxylation (GO:0019511) | 4.94836600 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 4.38302911 |
| 3 | protein hydroxylation (GO:0018126) | 4.30315841 |
| 4 | rRNA methylation (GO:0031167) | 4.09314201 |
| 5 | chromosome condensation (GO:0030261) | 4.04693701 |
| 6 | negative regulation of necroptotic process (GO:0060546) | 3.98543107 |
| 7 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.98282231 |
| 8 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.98143168 |
| 9 | DNA packaging (GO:0006323) | 3.76504718 |
| 10 | rRNA modification (GO:0000154) | 3.69955723 |
| 11 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.66034740 |
| 12 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.61914428 |
| 13 | response to peptidoglycan (GO:0032494) | 3.61605665 |
| 14 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.60382176 |
| 15 | regulation of mast cell degranulation (GO:0043304) | 3.43534695 |
| 16 | regulation of necroptotic process (GO:0060544) | 3.37287230 |
| 17 | 4-hydroxyproline metabolic process (GO:0019471) | 3.36584738 |
| 18 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.27373626 |
| 19 | carnitine transmembrane transport (GO:1902603) | 3.21342589 |
| 20 | pentose-phosphate shunt (GO:0006098) | 3.21201493 |
| 21 | skeletal muscle contraction (GO:0003009) | 3.20933786 |
| 22 | positive regulation of odontogenesis (GO:0042482) | 3.19389583 |
| 23 | response to muramyl dipeptide (GO:0032495) | 3.17931339 |
| 24 | positive regulation of myotube differentiation (GO:0010831) | 3.16023020 |
| 25 | acrosome reaction (GO:0007340) | 3.13963751 |
| 26 | sperm motility (GO:0030317) | 3.10239091 |
| 27 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.06263541 |
| 28 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.98336063 |
| 29 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.93071406 |
| 30 | sperm capacitation (GO:0048240) | 2.88557551 |
| 31 | negative regulation of necrotic cell death (GO:0060547) | 2.88276651 |
| 32 | NIK/NF-kappaB signaling (GO:0038061) | 2.88061526 |
| 33 | cellular response to arsenic-containing substance (GO:0071243) | 2.84996703 |
| 34 | microtubule depolymerization (GO:0007019) | 2.82044272 |
| 35 | carnitine transport (GO:0015879) | 2.82018068 |
| 36 | amino-acid betaine transport (GO:0015838) | 2.82018068 |
| 37 | regulation of leukocyte degranulation (GO:0043300) | 2.82014978 |
| 38 | binding of sperm to zona pellucida (GO:0007339) | 2.81301529 |
| 39 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.78711159 |
| 40 | positive regulation by symbiont of host defense response (GO:0052509) | 2.77642736 |
| 41 | modulation by symbiont of host defense response (GO:0052031) | 2.77642736 |
| 42 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.77642736 |
| 43 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.77642736 |
| 44 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.77642736 |
| 45 | modulation by symbiont of host immune response (GO:0052553) | 2.77642736 |
| 46 | germinal center formation (GO:0002467) | 2.75558359 |
| 47 | membrane protein ectodomain proteolysis (GO:0006509) | 2.74302768 |
| 48 | purine nucleotide salvage (GO:0032261) | 2.72566237 |
| 49 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.71818199 |
| 50 | regulation of necrotic cell death (GO:0010939) | 2.70656637 |
| 51 | NADPH regeneration (GO:0006740) | 2.70222303 |
| 52 | cellular hyperosmotic response (GO:0071474) | 2.70006213 |
| 53 | autophagic vacuole fusion (GO:0000046) | 2.69393291 |
| 54 | cell wall macromolecule catabolic process (GO:0016998) | 2.67273429 |
| 55 | spermatid nucleus differentiation (GO:0007289) | 2.67217793 |
| 56 | plasma membrane fusion (GO:0045026) | 2.66688043 |
| 57 | pinocytosis (GO:0006907) | 2.64295773 |
| 58 | pentose metabolic process (GO:0019321) | 2.61047989 |
| 59 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.60416086 |
| 60 | ether metabolic process (GO:0018904) | 2.58318675 |
| 61 | positive regulation of type 2 immune response (GO:0002830) | 2.56154147 |
| 62 | sexual reproduction (GO:0019953) | 2.56048448 |
| 63 | sperm-egg recognition (GO:0035036) | 2.55802215 |
| 64 | glucose catabolic process (GO:0006007) | 2.54823693 |
| 65 | negative regulation of granulocyte differentiation (GO:0030853) | 2.52760246 |
| 66 | spermatid development (GO:0007286) | 2.50863758 |
| 67 | glycerol ether metabolic process (GO:0006662) | 2.49340651 |
| 68 | motile cilium assembly (GO:0044458) | 2.47454596 |
| 69 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.46444257 |
| 70 | centriole assembly (GO:0098534) | 2.45635335 |
| 71 | ribosome assembly (GO:0042255) | 2.45283470 |
| 72 | RNA methylation (GO:0001510) | 2.45265602 |
| 73 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.45084106 |
| 74 | mitochondrial fusion (GO:0008053) | 2.42086730 |
| 75 | actin-myosin filament sliding (GO:0033275) | 2.41178009 |
| 76 | muscle filament sliding (GO:0030049) | 2.41178009 |
| 77 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.41163049 |
| 78 | positive regulation of mast cell degranulation (GO:0043306) | 2.41163049 |
| 79 | response to thyroid hormone (GO:0097066) | 2.41147036 |
| 80 | positive regulation of digestive system process (GO:0060456) | 2.40838736 |
| 81 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.40591014 |
| 82 | nucleotide salvage (GO:0043173) | 2.38589287 |
| 83 | negative regulation of cell size (GO:0045792) | 2.37482156 |
| 84 | definitive hemopoiesis (GO:0060216) | 2.37235861 |
| 85 | AMP metabolic process (GO:0046033) | 2.35691029 |
| 86 | amino sugar catabolic process (GO:0046348) | 2.35578203 |
| 87 | macrophage activation involved in immune response (GO:0002281) | 2.35029967 |
| 88 | toxin transport (GO:1901998) | 2.33491892 |
| 89 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.33040877 |
| 90 | peptide catabolic process (GO:0043171) | 2.32766979 |
| 91 | negative regulation of inclusion body assembly (GO:0090084) | 2.32252836 |
| 92 | regulation of monocyte differentiation (GO:0045655) | 2.30628070 |
| 93 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.30407976 |
| 94 | detection of other organism (GO:0098543) | 2.29012171 |
| 95 | regulation of skeletal muscle contraction (GO:0014819) | 2.28775142 |
| 96 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.28563778 |
| 97 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.24936130 |
| 98 | organelle membrane fusion (GO:0090174) | 2.24637737 |
| 99 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.24144819 |
| 100 | skeletal muscle adaptation (GO:0043501) | 2.23985162 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.65163276 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 2.55900568 |
| 3 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.51629471 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.50311921 |
| 5 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.46908188 |
| 6 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.35838925 |
| 7 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.33132739 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.29676672 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.08806003 |
| 10 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.97405660 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.89228459 |
| 12 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.87637218 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.82965282 |
| 14 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.81120350 |
| 15 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.81058270 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.77379913 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75686821 |
| 18 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.73634722 |
| 19 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.72736588 |
| 20 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.72609075 |
| 21 | MAF_26560356_Chip-Seq_TH1_Human | 1.70947943 |
| 22 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.70064875 |
| 23 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.67730533 |
| 24 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.66546744 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.65996221 |
| 26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.64738063 |
| 27 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.61823273 |
| 28 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.61676639 |
| 29 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.60381607 |
| 30 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.60375130 |
| 31 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.58425160 |
| 32 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.55700960 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.51159878 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.50155550 |
| 35 | UTX_26944678_Chip-Seq_JUKART_Human | 1.49394512 |
| 36 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.49206147 |
| 37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.48443817 |
| 38 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.47172618 |
| 39 | MAF_26560356_Chip-Seq_TH2_Human | 1.47158408 |
| 40 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.46421004 |
| 41 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.44040479 |
| 42 | SPI1_23127762_ChIP-Seq_K562_Human | 1.42881612 |
| 43 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.42339891 |
| 44 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.40251642 |
| 45 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.39383300 |
| 46 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.38320279 |
| 47 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.37957384 |
| 48 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37343520 |
| 49 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35922394 |
| 50 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.35396557 |
| 51 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.33435452 |
| 52 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.32944400 |
| 53 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.31967480 |
| 54 | GATA1_22025678_ChIP-Seq_K562_Human | 1.30650559 |
| 55 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28953952 |
| 56 | P68_20966046_ChIP-Seq_HELA_Human | 1.28706538 |
| 57 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.28203994 |
| 58 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.27867471 |
| 59 | MYB_26560356_Chip-Seq_TH2_Human | 1.27776283 |
| 60 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23860883 |
| 61 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.22939142 |
| 62 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.21427403 |
| 63 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20783427 |
| 64 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.20619567 |
| 65 | MYB_26560356_Chip-Seq_TH1_Human | 1.20349352 |
| 66 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.19343783 |
| 67 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.18640956 |
| 68 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.17224280 |
| 69 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.16722238 |
| 70 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.16528738 |
| 71 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16007654 |
| 72 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.15308916 |
| 73 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.15306399 |
| 74 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.14415482 |
| 75 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.13571291 |
| 76 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.12989537 |
| 77 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.12781317 |
| 78 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12761375 |
| 79 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10841888 |
| 80 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10540193 |
| 81 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.10106353 |
| 82 | ATF3_27146783_Chip-Seq_COLON_Human | 1.10038359 |
| 83 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.09366057 |
| 84 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.09324104 |
| 85 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.08067304 |
| 86 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.07126676 |
| 87 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.06452458 |
| 88 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.06306512 |
| 89 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.06237333 |
| 90 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06044804 |
| 91 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.05314182 |
| 92 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.03823957 |
| 93 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03667211 |
| 94 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.01349001 |
| 95 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00816909 |
| 96 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.00748668 |
| 97 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00741505 |
| 98 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00287925 |
| 99 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.00276662 |
| 100 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.99838780 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 4.76146541 |
| 2 | MP0005410_abnormal_fertilization | 3.24408440 |
| 3 | MP0009278_abnormal_bone_marrow | 3.16496633 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 3.08319774 |
| 5 | MP0002132_abnormal_respiratory_system | 2.80880736 |
| 6 | MP0004233_abnormal_muscle_weight | 2.51925433 |
| 7 | MP0008260_abnormal_autophagy | 2.38680627 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.33281538 |
| 9 | MP0005397_hematopoietic_system_phenotyp | 2.27282981 |
| 10 | MP0001545_abnormal_hematopoietic_system | 2.27282981 |
| 11 | MP0003646_muscle_fatigue | 2.27185790 |
| 12 | MP0005058_abnormal_lysosome_morphology | 2.25261374 |
| 13 | MP0003303_peritoneal_inflammation | 2.16599772 |
| 14 | MP0003436_decreased_susceptibility_to | 1.99861381 |
| 15 | MP0005464_abnormal_platelet_physiology | 1.98572885 |
| 16 | MP0000749_muscle_degeneration | 1.76589805 |
| 17 | MP0005083_abnormal_biliary_tract | 1.73556618 |
| 18 | MP0003828_pulmonary_edema | 1.72953130 |
| 19 | MP0000751_myopathy | 1.66374808 |
| 20 | MP0006036_abnormal_mitochondrial_physio | 1.64404465 |
| 21 | MP0002419_abnormal_innate_immunity | 1.59995466 |
| 22 | MP0001661_extended_life_span | 1.51791024 |
| 23 | MP0003724_increased_susceptibility_to | 1.49697030 |
| 24 | MP0002332_abnormal_exercise_endurance | 1.48521723 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 1.47557898 |
| 26 | MP0005330_cardiomyopathy | 1.43634049 |
| 27 | MP0000678_abnormal_parathyroid_gland | 1.43165751 |
| 28 | MP0004087_abnormal_muscle_fiber | 1.40683290 |
| 29 | MP0005670_abnormal_white_adipose | 1.38229204 |
| 30 | MP0002269_muscular_atrophy | 1.38144384 |
| 31 | MP0003191_abnormal_cellular_cholesterol | 1.37974684 |
| 32 | MP0004484_altered_response_of | 1.36845855 |
| 33 | MP0000747_muscle_weakness | 1.35012253 |
| 34 | MP0004036_abnormal_muscle_relaxation | 1.34740690 |
| 35 | MP0004808_abnormal_hematopoietic_stem | 1.34598361 |
| 36 | MP0000750_abnormal_muscle_regeneration | 1.34302554 |
| 37 | MP0004510_myositis | 1.32675317 |
| 38 | MP0002396_abnormal_hematopoietic_system | 1.32192123 |
| 39 | MP0000759_abnormal_skeletal_muscle | 1.31724108 |
| 40 | MP0003221_abnormal_cardiomyocyte_apopto | 1.31162239 |
| 41 | MP0005000_abnormal_immune_tolerance | 1.31032733 |
| 42 | MP0000858_altered_metastatic_potential | 1.28657039 |
| 43 | MP0000343_altered_response_to | 1.27759362 |
| 44 | MP0002148_abnormal_hypersensitivity_rea | 1.24118107 |
| 45 | MP0005025_abnormal_response_to | 1.22776563 |
| 46 | MP0003656_abnormal_erythrocyte_physiolo | 1.22571402 |
| 47 | MP0002452_abnormal_antigen_presenting | 1.20797004 |
| 48 | MP0005076_abnormal_cell_differentiation | 1.20116192 |
| 49 | MP0000465_gastrointestinal_hemorrhage | 1.17154616 |
| 50 | MP0010630_abnormal_cardiac_muscle | 1.16717638 |
| 51 | MP0001849_ear_inflammation | 1.16300669 |
| 52 | MP0002723_abnormal_immune_serum | 1.12045001 |
| 53 | MP0001853_heart_inflammation | 1.11642112 |
| 54 | MP0002420_abnormal_adaptive_immunity | 1.10250716 |
| 55 | MP0001819_abnormal_immune_cell | 1.09954419 |
| 56 | MP0002398_abnormal_bone_marrow | 1.09192835 |
| 57 | MP0002722_abnormal_immune_system | 1.08244924 |
| 58 | MP0004947_skin_inflammation | 1.07415352 |
| 59 | MP0009785_altered_susceptibility_to | 1.07412831 |
| 60 | MP0004185_abnormal_adipocyte_glucose | 1.05579168 |
| 61 | MP0000685_abnormal_immune_system | 1.04071782 |
| 62 | MP0005666_abnormal_adipose_tissue | 1.03908632 |
| 63 | MP0002106_abnormal_muscle_physiology | 1.03384109 |
| 64 | MP0001533_abnormal_skeleton_physiology | 1.03233650 |
| 65 | MP0000689_abnormal_spleen_morphology | 1.02417149 |
| 66 | MP0003091_abnormal_cell_migration | 1.02101236 |
| 67 | MP0001929_abnormal_gametogenesis | 1.02075343 |
| 68 | MP0000681_abnormal_thyroid_gland | 0.99737953 |
| 69 | MP0003705_abnormal_hypodermis_morpholog | 0.99116177 |
| 70 | MP0003172_abnormal_lysosome_physiology | 0.97796173 |
| 71 | MP0009840_abnormal_foam_cell | 0.97030081 |
| 72 | MP0002127_abnormal_cardiovascular_syste | 0.94725040 |
| 73 | MP0000716_abnormal_immune_system | 0.94704491 |
| 74 | MP0002429_abnormal_blood_cell | 0.92569527 |
| 75 | MP0003698_abnormal_male_reproductive | 0.92475255 |
| 76 | MP0005164_abnormal_response_to | 0.92274693 |
| 77 | MP0005310_abnormal_salivary_gland | 0.91389468 |
| 78 | MP0002998_abnormal_bone_remodeling | 0.91375040 |
| 79 | MP0000703_abnormal_thymus_morphology | 0.90111138 |
| 80 | MP0008469_abnormal_protein_level | 0.89222797 |
| 81 | MP0003077_abnormal_cell_cycle | 0.89175087 |
| 82 | MP0005375_adipose_tissue_phenotype | 0.87871094 |
| 83 | MP0008007_abnormal_cellular_replicative | 0.87839646 |
| 84 | MP0001845_abnormal_inflammatory_respons | 0.87484301 |
| 85 | MP0010155_abnormal_intestine_physiology | 0.86932061 |
| 86 | MP0000733_abnormal_muscle_development | 0.86407896 |
| 87 | MP0005165_increased_susceptibility_to | 0.86359087 |
| 88 | MP0001800_abnormal_humoral_immune | 0.85742755 |
| 89 | MP0000003_abnormal_adipose_tissue | 0.84451504 |
| 90 | MP0002405_respiratory_system_inflammati | 0.84169015 |
| 91 | MP0003300_gastrointestinal_ulcer | 0.83109357 |
| 92 | MP0006082_CNS_inflammation | 0.81690757 |
| 93 | MP0002971_abnormal_brown_adipose | 0.80760865 |
| 94 | MP0003763_abnormal_thymus_physiology | 0.80737344 |
| 95 | MP0000490_abnormal_crypts_of | 0.80709242 |
| 96 | MP0002019_abnormal_tumor_incidence | 0.80668224 |
| 97 | MP0003111_abnormal_nucleus_morphology | 0.79742640 |
| 98 | MP0006035_abnormal_mitochondrial_morpho | 0.79661966 |
| 99 | MP0003453_abnormal_keratinocyte_physiol | 0.79298608 |
| 100 | MP0001790_abnormal_immune_system | 0.75850200 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 4.92612489 |
| 2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.85904498 |
| 3 | Nemaline bodies (HP:0003798) | 4.71804441 |
| 4 | Asymmetric septal hypertrophy (HP:0001670) | 4.21972609 |
| 5 | Exercise-induced myalgia (HP:0003738) | 4.14513111 |
| 6 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.96042638 |
| 7 | Distal lower limb muscle weakness (HP:0009053) | 3.78773793 |
| 8 | Rhabdomyolysis (HP:0003201) | 3.68588742 |
| 9 | Myoglobinuria (HP:0002913) | 3.63700947 |
| 10 | Myopathic facies (HP:0002058) | 3.55912019 |
| 11 | Loss of speech (HP:0002371) | 3.33774713 |
| 12 | Bulbar palsy (HP:0001283) | 3.27544469 |
| 13 | EMG: myopathic abnormalities (HP:0003458) | 3.26488416 |
| 14 | Rimmed vacuoles (HP:0003805) | 3.23169381 |
| 15 | Increased connective tissue (HP:0009025) | 3.19328559 |
| 16 | Fatigue (HP:0012378) | 3.14101456 |
| 17 | Distal lower limb amyotrophy (HP:0008944) | 3.07977918 |
| 18 | Ragged-red muscle fibers (HP:0003200) | 3.06661203 |
| 19 | Type 1 muscle fiber predominance (HP:0003803) | 2.97070937 |
| 20 | Exercise-induced muscle cramps (HP:0003710) | 2.92878984 |
| 21 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.84365659 |
| 22 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.84365659 |
| 23 | Abnormality of glycolipid metabolism (HP:0010969) | 2.84365659 |
| 24 | Progressive muscle weakness (HP:0003323) | 2.82693462 |
| 25 | Nasal polyposis (HP:0100582) | 2.82229816 |
| 26 | Polycythemia (HP:0001901) | 2.79752490 |
| 27 | Vertebral compression fractures (HP:0002953) | 2.75353796 |
| 28 | Muscle fiber splitting (HP:0003555) | 2.67684423 |
| 29 | Testicular neoplasm (HP:0010788) | 2.56241881 |
| 30 | Neck muscle weakness (HP:0000467) | 2.54973665 |
| 31 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.54152399 |
| 32 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.51879070 |
| 33 | Abnormality of macrophages (HP:0004311) | 2.50374356 |
| 34 | Hyporeflexia of lower limbs (HP:0002600) | 2.48849060 |
| 35 | Abnormality of the nasal mucosa (HP:0000433) | 2.47616091 |
| 36 | Male infertility (HP:0003251) | 2.45586279 |
| 37 | Myositis (HP:0100614) | 2.44600284 |
| 38 | Difficulty climbing stairs (HP:0003551) | 2.44079744 |
| 39 | Cholecystitis (HP:0001082) | 2.37649629 |
| 40 | Abnormal gallbladder physiology (HP:0012438) | 2.37649629 |
| 41 | Gonadal dysgenesis (HP:0000133) | 2.36680763 |
| 42 | Obstructive lung disease (HP:0006536) | 2.31897916 |
| 43 | Chronic obstructive pulmonary disease (HP:0006510) | 2.31897916 |
| 44 | Increased cerebral lipofuscin (HP:0011813) | 2.25933768 |
| 45 | Cone-rod dystrophy (HP:0000548) | 2.24945058 |
| 46 | Resting tremor (HP:0002322) | 2.16964980 |
| 47 | Distal arthrogryposis (HP:0005684) | 2.15329955 |
| 48 | Muscle stiffness (HP:0003552) | 2.14161292 |
| 49 | Ulnar deviation of the wrist (HP:0003049) | 2.08935536 |
| 50 | Upper motor neuron abnormality (HP:0002127) | 2.08920794 |
| 51 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.08018960 |
| 52 | Absent/shortened dynein arms (HP:0200106) | 2.08018960 |
| 53 | Gastrointestinal inflammation (HP:0004386) | 2.07586018 |
| 54 | Hepatosplenomegaly (HP:0001433) | 2.01021883 |
| 55 | Shoulder girdle muscle weakness (HP:0003547) | 2.00984283 |
| 56 | Hypertensive crisis (HP:0100735) | 1.99830030 |
| 57 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.98435714 |
| 58 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.97293279 |
| 59 | Mediastinal lymphadenopathy (HP:0100721) | 1.96429172 |
| 60 | Recurrent abscess formation (HP:0002722) | 1.95379950 |
| 61 | Prolonged bleeding time (HP:0003010) | 1.94144681 |
| 62 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.94079483 |
| 63 | Easy fatigability (HP:0003388) | 1.93567727 |
| 64 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.93409510 |
| 65 | Ventricular tachycardia (HP:0004756) | 1.92226759 |
| 66 | Increased variability in muscle fiber diameter (HP:0003557) | 1.91926596 |
| 67 | Colitis (HP:0002583) | 1.91117109 |
| 68 | Increased serum ferritin (HP:0003281) | 1.91083670 |
| 69 | Abnormality of lateral ventricle (HP:0030047) | 1.89834589 |
| 70 | Epistaxis (HP:0000421) | 1.88668756 |
| 71 | Malignant hyperthermia (HP:0002047) | 1.88356292 |
| 72 | Inflammation of the large intestine (HP:0002037) | 1.87649203 |
| 73 | Abnormal large intestine physiology (HP:0012700) | 1.83220737 |
| 74 | Hypertriglyceridemia (HP:0002155) | 1.83147079 |
| 75 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.82927208 |
| 76 | Foot dorsiflexor weakness (HP:0009027) | 1.82734511 |
| 77 | Bowel incontinence (HP:0002607) | 1.82160663 |
| 78 | Reduced antithrombin III activity (HP:0001976) | 1.82028377 |
| 79 | Eczematoid dermatitis (HP:0000976) | 1.81863890 |
| 80 | Scapular winging (HP:0003691) | 1.81612585 |
| 81 | Severe visual impairment (HP:0001141) | 1.81476209 |
| 82 | Chest pain (HP:0100749) | 1.78414836 |
| 83 | Pelvic girdle muscle weakness (HP:0003749) | 1.75748780 |
| 84 | Short nail (HP:0001799) | 1.74478658 |
| 85 | Trismus (HP:0000211) | 1.74404299 |
| 86 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.74056051 |
| 87 | Areflexia of lower limbs (HP:0002522) | 1.73517538 |
| 88 | Orchitis (HP:0100796) | 1.73177502 |
| 89 | Petechiae (HP:0000967) | 1.72887953 |
| 90 | Multiple enchondromatosis (HP:0005701) | 1.72512029 |
| 91 | Achilles tendon contracture (HP:0001771) | 1.71652768 |
| 92 | Difficulty running (HP:0009046) | 1.71000819 |
| 93 | Acute hepatic failure (HP:0006554) | 1.70654941 |
| 94 | Abnormality of the costochondral junction (HP:0000919) | 1.70297920 |
| 95 | Purpura (HP:0000979) | 1.69377498 |
| 96 | Granulocytopenia (HP:0001913) | 1.68896226 |
| 97 | Cellulitis (HP:0100658) | 1.68684970 |
| 98 | Generalized muscle weakness (HP:0003324) | 1.68202729 |
| 99 | Thrombocytosis (HP:0001894) | 1.66682512 |
| 100 | Abnormality of the foot musculature (HP:0001436) | 1.65111338 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP2K3 | 4.00243132 |
| 2 | PBK | 3.43378477 |
| 3 | SCYL2 | 2.99921551 |
| 4 | IRAK3 | 2.71148913 |
| 5 | PLK4 | 2.60047582 |
| 6 | TRIB3 | 2.57208619 |
| 7 | ERN1 | 2.49722236 |
| 8 | NME2 | 2.35556975 |
| 9 | TTN | 2.35371809 |
| 10 | OBSCN | 2.31255808 |
| 11 | TESK1 | 2.01442984 |
| 12 | TBK1 | 2.00279765 |
| 13 | PRPF4B | 1.75151288 |
| 14 | CCNB1 | 1.72366205 |
| 15 | MAP4K1 | 1.67513321 |
| 16 | RIPK4 | 1.64747987 |
| 17 | TESK2 | 1.59316971 |
| 18 | MAP3K14 | 1.58256274 |
| 19 | MAP3K13 | 1.56936254 |
| 20 | MAP3K1 | 1.52301128 |
| 21 | TAOK2 | 1.51761533 |
| 22 | SMG1 | 1.46962206 |
| 23 | TAOK3 | 1.41700681 |
| 24 | MAP3K3 | 1.40765396 |
| 25 | MAP3K6 | 1.37862243 |
| 26 | NEK9 | 1.33394050 |
| 27 | ICK | 1.30955612 |
| 28 | MOS | 1.30792941 |
| 29 | PAK4 | 1.29792121 |
| 30 | ARAF | 1.24292078 |
| 31 | MAP3K11 | 1.22551738 |
| 32 | JAK3 | 1.21550734 |
| 33 | ZAP70 | 1.10490110 |
| 34 | EPHB1 | 1.06922798 |
| 35 | KSR2 | 1.06784428 |
| 36 | CDK4 | 1.05434926 |
| 37 | PDPK1 | 1.05097336 |
| 38 | PIK3CG | 1.04856531 |
| 39 | IRAK4 | 1.04735302 |
| 40 | RPS6KB2 | 1.03096877 |
| 41 | TGFBR2 | 1.02619469 |
| 42 | EPHA2 | 1.00583571 |
| 43 | GRK6 | 0.98594391 |
| 44 | BMPR2 | 0.97955247 |
| 45 | BCKDK | 0.95528298 |
| 46 | MST1R | 0.94957399 |
| 47 | IRAK2 | 0.91940209 |
| 48 | MAP2K6 | 0.85039805 |
| 49 | TNK2 | 0.85029591 |
| 50 | TYK2 | 0.84587278 |
| 51 | CDK7 | 0.83297587 |
| 52 | VRK2 | 0.81720332 |
| 53 | MAP3K5 | 0.80970752 |
| 54 | KIT | 0.79864854 |
| 55 | BLK | 0.78875565 |
| 56 | CDK12 | 0.77507974 |
| 57 | DDR2 | 0.76171784 |
| 58 | PRKD3 | 0.74696324 |
| 59 | PDK1 | 0.74400781 |
| 60 | MAP2K4 | 0.73883339 |
| 61 | NEK6 | 0.73652735 |
| 62 | IKBKB | 0.67474584 |
| 63 | STK10 | 0.67048351 |
| 64 | PIM2 | 0.66881284 |
| 65 | MARK3 | 0.65189799 |
| 66 | BTK | 0.64547744 |
| 67 | RPS6KC1 | 0.63461489 |
| 68 | RPS6KL1 | 0.63461489 |
| 69 | SIK1 | 0.63295230 |
| 70 | MAP3K8 | 0.62879325 |
| 71 | AKT2 | 0.62837125 |
| 72 | PKN2 | 0.61756735 |
| 73 | FLT3 | 0.61136574 |
| 74 | CSF1R | 0.59695310 |
| 75 | TAOK1 | 0.59496778 |
| 76 | MAPK7 | 0.58914334 |
| 77 | CDK6 | 0.58524965 |
| 78 | STK38 | 0.57682010 |
| 79 | FGR | 0.56899569 |
| 80 | CSK | 0.56723332 |
| 81 | IKBKE | 0.55451055 |
| 82 | BMX | 0.54740794 |
| 83 | MAP2K2 | 0.54224176 |
| 84 | MTOR | 0.53401298 |
| 85 | PDK2 | 0.52404502 |
| 86 | EIF2AK1 | 0.48420542 |
| 87 | PTK6 | 0.45434768 |
| 88 | CDK8 | 0.45003499 |
| 89 | MAPK11 | 0.44714744 |
| 90 | RET | 0.44251081 |
| 91 | MAP3K7 | 0.42880113 |
| 92 | RPS6KA4 | 0.42479030 |
| 93 | MAPK12 | 0.41218037 |
| 94 | PAK1 | 0.41161638 |
| 95 | SIK3 | 0.41003016 |
| 96 | RPS6KA6 | 0.40225659 |
| 97 | DYRK1B | 0.39924244 |
| 98 | MATK | 0.38571460 |
| 99 | PRKG2 | 0.37925584 |
| 100 | MAPKAPK3 | 0.35019003 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.52441558 |
| 2 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.37768507 |
| 3 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.16145522 |
| 4 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.93366170 |
| 5 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.87991459 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.86180305 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 1.82855682 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.76796888 |
| 9 | DNA replication_Homo sapiens_hsa03030 | 1.71395956 |
| 10 | Lysosome_Homo sapiens_hsa04142 | 1.69357574 |
| 11 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.62890200 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 1.61100340 |
| 13 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.60588619 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.56080988 |
| 15 | Base excision repair_Homo sapiens_hsa03410 | 1.51340900 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.49510648 |
| 17 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.44356402 |
| 18 | Legionellosis_Homo sapiens_hsa05134 | 1.40970512 |
| 19 | Influenza A_Homo sapiens_hsa05164 | 1.37961317 |
| 20 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.35414661 |
| 21 | Shigellosis_Homo sapiens_hsa05131 | 1.34842486 |
| 22 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.31516853 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.30064764 |
| 24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.29372567 |
| 25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.29206674 |
| 26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.26729649 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.26447733 |
| 28 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.25038330 |
| 29 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.22818427 |
| 30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.21528580 |
| 31 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.20957212 |
| 32 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.20858655 |
| 33 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.20301469 |
| 34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.19214517 |
| 35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.17048010 |
| 36 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.15098346 |
| 37 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.12876289 |
| 38 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.12768521 |
| 39 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.11008929 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 1.07044135 |
| 41 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.98780219 |
| 42 | Bladder cancer_Homo sapiens_hsa05219 | 0.97879736 |
| 43 | Galactose metabolism_Homo sapiens_hsa00052 | 0.97338783 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 0.97300213 |
| 45 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.95778499 |
| 46 | Measles_Homo sapiens_hsa05162 | 0.95320443 |
| 47 | Platelet activation_Homo sapiens_hsa04611 | 0.94865446 |
| 48 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.94313642 |
| 49 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.92675637 |
| 50 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.92497235 |
| 51 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.90735306 |
| 52 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.88508605 |
| 53 | RNA transport_Homo sapiens_hsa03013 | 0.88225561 |
| 54 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.87583970 |
| 55 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.86178911 |
| 56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.85932912 |
| 57 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.85761784 |
| 58 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.83143168 |
| 59 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.82903661 |
| 60 | Insulin resistance_Homo sapiens_hsa04931 | 0.82230787 |
| 61 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.82046344 |
| 62 | Endocytosis_Homo sapiens_hsa04144 | 0.81873164 |
| 63 | Thyroid cancer_Homo sapiens_hsa05216 | 0.80995049 |
| 64 | HTLV-I infection_Homo sapiens_hsa05166 | 0.80585169 |
| 65 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.80539290 |
| 66 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.80075300 |
| 67 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.79134582 |
| 68 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.78967311 |
| 69 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.78554596 |
| 70 | Spliceosome_Homo sapiens_hsa03040 | 0.77891333 |
| 71 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.77305261 |
| 72 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.76013860 |
| 73 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.75178095 |
| 74 | Salmonella infection_Homo sapiens_hsa05132 | 0.74416018 |
| 75 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.73667803 |
| 76 | Hepatitis C_Homo sapiens_hsa05160 | 0.72004606 |
| 77 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.71191673 |
| 78 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.69231148 |
| 79 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.68976781 |
| 80 | Allograft rejection_Homo sapiens_hsa05330 | 0.68487682 |
| 81 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.67760590 |
| 82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.67236518 |
| 83 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.65808199 |
| 84 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.63404901 |
| 85 | Phagosome_Homo sapiens_hsa04145 | 0.62823560 |
| 86 | Malaria_Homo sapiens_hsa05144 | 0.61845173 |
| 87 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.61766231 |
| 88 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.59985843 |
| 89 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.59834724 |
| 90 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.58154955 |
| 91 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.55994530 |
| 92 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55375842 |
| 93 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.55025058 |
| 94 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.54407856 |
| 95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.53710396 |
| 96 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.53020796 |
| 97 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.52395620 |
| 98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51170197 |
| 99 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.50742761 |
| 100 | Pertussis_Homo sapiens_hsa05133 | 0.49232844 |

